|Last Price$21.68||Day Change (%)0.74%|
|Open Price$21.68||Day Change ($)0.16|
|Day Range21.68–21.68||52-Week Range18.61–24.75|
As of Wed 02/21/2017 | USD
Mylan shares drop 1.4% after Bloomberg report says it's facing U.S. antitrust investigation over EpiPen
Watson Pharmaceuticals WPI scored big Tuesday when the Food and Drug Administration approved the firm's generic fentanyl patch. We may modestly increase our fair value estimate for Watson and will maintain our fair value estimate for competitor Mylan Laboratories MYL . The pain patch is one of the ...
Mylan Laboratories MYL reported impressive second-quarter results Wednesday. However, most of the improvement was temporary and will not affect our fair value estimate. The quarter was only slightly better than we expected after excluding a one-time litigation payment and proceeds from a product ...
MARKET SNAPSHOT: Nasdaq Nears Longest Record-setting Streak Since 1999
UPDATE: Nasdaq nears longest record-setting streak since 1999
UPDATE: Einhorn buys Syngenta, Voya, Apple, dumps Michael Kors in 4th quarter
MARKET SNAPSHOT: S&P 500 Aims For Longest Win Streak In 3 1/2 Years, But Futures Waver
UPDATE: S&P 500 aims for longest win streak in 3 1/2 years, but futures waver
MARKET SNAPSHOT: Stock Market Carves Out Fresh Ground In Record Territory
UPDATE: Stock market carves out fresh ground in record territory